Evaluation of serum exosomal LncRNA‐based biomarker panel for diagnosis and recurrence prediction of bladder cancer. Issue 2 (23rd November 2018)
- Record Type:
- Journal Article
- Title:
- Evaluation of serum exosomal LncRNA‐based biomarker panel for diagnosis and recurrence prediction of bladder cancer. Issue 2 (23rd November 2018)
- Main Title:
- Evaluation of serum exosomal LncRNA‐based biomarker panel for diagnosis and recurrence prediction of bladder cancer
- Authors:
- Zhang, Shujun
Du, Lutao
Wang, Lishui
Jiang, Xiumei
Zhan, Yao
Li, Juan
Yan, Keqiang
Duan, Weili
Zhao, Yinghui
Wang, Lili
Wang, Yunshan
Shi, Yuliang
Wang, Chuanxin - Abstract:
- Abstract: Exosomes are small membrane vesicles released by many cells. These vesicles can mediate cellular communications by transmitting active molecules including long non‐coding RNAs (lncRNAs). In this study, our aim was to identify a panel of lncRNAs in serum exosomes for the diagnosis and recurrence prediction of bladder cancer (BC). The expressions of 11 candidate lncRNAs in exosome were investigated in training set (n = 200) and an independent validation set (n = 320) via quantitative real‐time PCR. A three‐lncRNA panel (PCAT‐1, UBC1 and SNHG16) was finally identified by multivariate logistic regression model to provide high diagnostic accuracy for BC with an area under the receiver‐operating characteristic curve (AUC) of 0.857 and 0.826 in training set and validation set, respectively, which was significantly higher than that of urine cytology. The corresponding AUCs of this panel for patients with Ta, T1 and T2‐T4 were 0.760, 0.827 and 0.878, respectively. In addition, Kaplan‐Meier analysis showed that non‐muscle‐invasive BC (NMIBC) patients with high UBC1 expression had significantly lower recurrence‐free survival ( P = 0.01). Multivariate Cox analysis demonstrated that UBC1 was independently associated with tumour recurrence of NMIBC ( P = 0.018). Our study suggested that lncRNAs in serum exosomes may serve as considerable diagnostic and prognostic biomarkers of BC.
- Is Part Of:
- Journal of cellular and molecular medicine. Volume 23:Issue 2(2019)
- Journal:
- Journal of cellular and molecular medicine
- Issue:
- Volume 23:Issue 2(2019)
- Issue Display:
- Volume 23, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 23
- Issue:
- 2
- Issue Sort Value:
- 2019-0023-0002-0000
- Page Start:
- 1396
- Page End:
- 1405
- Publication Date:
- 2018-11-23
- Subjects:
- biomarkers -- bladder cancer -- diagnosis -- long non‐coding RNA -- recurrence -- serum exosomes
Cytology
Medicine
Molecular Biology
Cytologie -- Périodiques
Médecine -- Périodiques
Biologie moléculaire -- Périodiques
Cytology -- Periodicals
Medicine -- Periodicals
Molecular biology -- Periodicals
611.01805 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1582-4934 ↗
http://www.blackwell-synergy.com/loi/jcmm ↗
http://www.usc.edu/hsc/nml/e-resources/info/joucelmm.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jcmm.14042 ↗
- Languages:
- English
- ISSNs:
- 1582-1838
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.005000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9455.xml